Lynn H Bichajian MD
Clinical Pharmacology
Senior Medical Director, Clinical Drug Development, Eagle Pharmaceuticals
Join to view full profile
Eagle Pharmaceuticals, Inc.50 Tice Blvd, Suite 315Woodcliff Lake, NJ 07677
Phone+1 508-397-7335
Dr. Bichajian is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Seasoned Senior Medical Director with over 10 years in the pharmaceutical industry and 25 years as a board-certified anesthesiologist. Expertise in clinical development, medical affairs, and regulatory strategy, with a focus on anesthesia and pain management. Demonstrated success in managing Phase I-IV trials, FDA interactions, and cross-functional leadership, complemented by impactful publications and research in Anesthesiology.
Education & Training
Mass General Brigham/Brigham and Women's HospitalChief Residency, Anesthesiology, 1993 - 1994- Mass General Brigham/Brigham and Women's HospitalResidency, Anesthesiology, 1991 - 1994
University of Miami/Jackson Health SystemInternship, Internal Medicine, 1990 - 1991
University of Miami Leonard M. Miller School of MedicineClass of 1990
Cornell UniversityBA, Psychology, 1982 - 1984
Certifications & Licensure
MA State Medical License 1994 - 2017
American Board of Anesthesiology Anesthesiology
Publications & Presentations
PubMed
- Pharmacokinetics and Pharmacodynamics of Remimazolam for Procedural Sedation in Children and Adolescents.Pieter J Colin, Lynn H Bichajian, Valentin R Curt, Jeroen V Koomen, Thomas Stöhr
Anesthesiology. 2025-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
